LifeStance Health (LFST) Operating Expenses (2020 - 2026)

LifeStance Health has disclosed Operating Expenses across 7 years of filings, most recently posting $381.2 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 15.04% year-over-year to $381.2 million; the TTM figure through Mar 2026 stood at $1.4 billion (up 11.82% YoY), while the FY2025 annual figure was $1.4 billion, up 9.17% from the prior year.
• Operating Expenses grew to $381.2 million in Q1 2026, from $364.1 million in the prior quarter.
• Over the last five years, Operating Expenses for LFST reached as high as $381.2 million in Q1 2026 and fell as low as $256.4 million in Q3 2022.
• The 5-year median for Operating Expenses is $317.2 million (2024), against an average of $316.4 million.
• The widest YoY moves for Operating Expenses: up 86.06% in 2022, down 14.11% in 2022.
• A 5-year view of Operating Expenses shows it stood at $275.4 million in 2022, then increased by 13.62% to $312.9 million in 2023, then advanced by 3.69% to $324.4 million in 2024, then grew by 12.23% to $364.1 million in 2025, then climbed by 4.69% to $381.2 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $381.2 million, $364.1 million, and $356.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.